Latest From Bowman Cox
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
Agency begins gathering manufacturing plant data to prepare for disruptions that can drain inventories over a weekend.
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.
Emerging global standard could speed testing of biologics and gene therapies for stray viral particles, while sparing laboratory animals.